What's Happening?
Médecins Sans Frontières (MSF), also known as Doctors Without Borders, will participate for the first time in the World Cancer Congress in Hong Kong in 2026. The international medical humanitarian organization plans to present its experiences and findings
from cancer programs in Mali and Malawi. MSF aims to highlight the feasibility of providing cancer care in resource-limited settings and emphasize the urgent need to overcome barriers to prevention, timely diagnosis, and adequate treatment. In Mali, over 2,300 women received medical care for breast or cervical cancer between 2021 and 2025 through MSF's program in Bamako. A retrospective study in Mali showed promising survival rates for breast cancer patients, with 91% after one year and 72% after three years, despite challenges like unreliable access to radiotherapy and security constraints. The proportion of cervical cancer patients diagnosed at an early stage in Mali doubled from 14% in 2019 to 28% in 2022. In Malawi, MSF's program in Blantyre addresses the world's second-highest cervical cancer mortality rate by improving access to palliative care, chemotherapy, surgery, radiotherapy, and prevention tools such as HPV vaccination and early screening. Cervical cancer screening coverage in Blantyre district increased from 40% in 2019 to nearly 60% last year. MSF also joined the PAVE study, an international research project testing a low-cost strategy for screening and treating pre-cancerous cervical lesions in resource-limited environments.
Why It's Important?
MSF's participation in the World Cancer Congress and its sharing of experiences from Mali and Malawi underscore a critical global health issue: the disparity in cancer care access and outcomes between high-income and resource-limited countries. The success stories from MSF's programs demonstrate that effective cancer interventions, including prevention, screening, diagnosis, and treatment, are achievable even in challenging environments. This is particularly important for the U.S. as it highlights the potential for international collaboration and knowledge exchange to improve global health equity. The insights gained from MSF's work can inform strategies for delivering care in underserved communities worldwide, including those within the U.S. that face similar access barriers. By showcasing practical models for cancer care in difficult contexts, MSF's presentation could influence global health policy and funding priorities, encouraging greater investment in accessible cancer solutions. Furthermore, the focus on cervical cancer, a preventable and treatable disease, emphasizes the importance of public health initiatives like vaccination and early screening, which are also relevant to U.S. public health efforts to reduce cancer burdens.
What's Next?
Following its presentation at the World Cancer Congress, MSF will likely continue to advocate for increased global attention and resources for cancer care in humanitarian and resource-limited settings. The organization's involvement in the PAVE study suggests an ongoing commitment to developing and implementing innovative, low-cost screening and treatment strategies. Future efforts may include expanding these successful models to other regions facing similar challenges and collaborating with international bodies and governments to integrate these approaches into national health policies. MSF will likely continue to publish research and data from its programs to further inform the global health community and demonstrate the impact of its interventions. The organization may also seek to influence pharmaceutical companies and policymakers to improve the accessibility and affordability of essential cancer medicines and technologies in these regions. The discussions at the Congress could lead to new partnerships and funding opportunities, enabling MSF to scale up its cancer care initiatives and reach more vulnerable populations.
Beyond the Headlines
The broader implications of MSF's work extend beyond immediate medical care, touching upon ethical considerations of global health equity and the long-term sustainability of healthcare systems in fragile states. The organization's commitment to providing care 'solely based on need, irrespective of race, religion, gender, or political affiliation' challenges conventional approaches to healthcare delivery, particularly in conflict zones or areas with weak governance. This model emphasizes the universal right to health and highlights the moral imperative for the international community to support such efforts. The focus on cancer, a non-communicable disease often overlooked in humanitarian crises, signals a shift in the scope of emergency medical aid, recognizing the complex and chronic health needs of affected populations. MSF's advocacy for breaking barriers to access also implicitly critiques the global pharmaceutical market and intellectual property regimes that can hinder the availability of life-saving treatments in poorer countries. This work contributes to a larger discourse on global health justice, urging a re-evaluation of how medical resources are distributed and how healthcare innovations are made accessible to all.
